JP

Jignesh Prabhulal Rabadia

Director Partner DIN 08009125
DIN 08009125 First appointment Dec 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2017
Shareholding value •••• Premium profile

About Jignesh Prabhulal Rabadia

Data last updated:

Jignesh Prabhulal Rabadia was a Partner at Achyut Lifesciences Llp (2021–2025) and Director at Nuviton Healthcare Private Limited (2017–2020). The companies operate in Pharma and Food And Beverages.

DIN 08009125
Primary Designation Partner
Industry Pharma
First Appointment 19 Dec 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner11 Dec 20212017Active
Nuviton Healthcare Private Limited U24303GJ2017PTC100200
Director19 Dec 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Achyut Lifesciences Llp
Nuviton Healthcare Private Limited
Premium access

Shareholding and investment profile for Jignesh Prabhulal Rabadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jignesh Prabhulal Rabadia

Jignesh Prabhulal Rabadia was first appointed on 19 Dec 2017 as Director at Nuviton Healthcare Private Limited. The most recent appointment on record is 11 Dec 2021 at Achyut Lifesciences Llp.

Jignesh Prabhulal Rabadia held 2 earlier board appointments: Achyut Lifesciences Llp (Partner, 11 Dec 2021 to 24 Jan 2025); Nuviton Healthcare Private Limited (Director, 19 Dec 2017 to 01 Jul 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available